{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T18:11:16Z","timestamp":1788459076983,"version":"build-2803163510"},"reference-count":31,"publisher":"Society of Nuclear Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Nucl. Med. Technol."],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.2967\/jnmt.121.263502","type":"journal-article","created":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T19:00:15Z","timestamp":1655233215000},"page":"233-239","source":"Crossref","is-referenced-by-count":3,"title":["Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy"],"prefix":"10.2967","volume":"50","author":[{"given":"Caio Vinicius","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane Sabriela Cagol","family":"Camozzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia Fernanda","family":"Dorow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica","family":"Pasqueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"2023061212152760000_50.3.233.1","unstructured":"C\u00e2ncer de tireoide. gov.br website. https:\/\/www.inca.gov.br\/tipos-de-cancer\/cancer-de-tireoide. Published June 4, 2022. Accessed August 1, 2022."},{"key":"2023061212152760000_50.3.233.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0883-1"},{"key":"2023061212152760000_50.3.233.3","doi-asserted-by":"crossref","first-page":"e835","DOI":"10.6061\/clinics\/2019\/e835","article-title":"Radionuclide therapy: current status and prospects for internal dosimetry in individualized therapeutic planning","volume":"74","author":"Sapienza","year":"2019","journal-title":"Clinics (Sao Paulo)."},{"key":"2023061212152760000_50.3.233.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1345"},{"key":"2023061212152760000_50.3.233.5","first-page":"1587","article-title":"Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer","volume":"47","author":"Tuttle","year":"2006","journal-title":"J Nucl Med."},{"key":"2023061212152760000_50.3.233.6","unstructured":"Smilgys B . Radioiodine therapy of differentiated thyroid cancer with simplified personalized dosimetry [in Portuguese] [master\u2019s dissertation]. State University of Campinas; 2018."},{"key":"2023061212152760000_50.3.233.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1230-1"},{"key":"2023061212152760000_50.3.233.8","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.179366"},{"key":"2023061212152760000_50.3.233.9","doi-asserted-by":"publisher","DOI":"10.1109\/23.737672"},{"key":"2023061212152760000_50.3.233.10","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.122390"},{"key":"2023061212152760000_50.3.233.11","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0761-x"},{"key":"2023061212152760000_50.3.233.12","first-page":"899","article-title":"Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer","volume":"46","author":"Sgouros","year":"2005","journal-title":"J Nucl Med."},{"key":"2023061212152760000_50.3.233.13","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-09-0076"},{"key":"2023061212152760000_50.3.233.14","doi-asserted-by":"publisher","DOI":"10.1016\/0969-8051(93)90108-7"},{"key":"2023061212152760000_50.3.233.15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood.V33.5.649.649","article-title":"Erythrocyte volume, plasma volume, and lean body mass in adult men and women","volume":"33","author":"Retzlaff","year":"1969","journal-title":"Blood."},{"key":"2023061212152760000_50.3.233.16","first-page":"171","article-title":"The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer","volume":"87","author":"Benua","year":"1962","journal-title":"AJR."},{"key":"2023061212152760000_50.3.233.17","first-page":"1985","article-title":"Lung dosimetry for radioiodine treatment planning in the case of diffuse lung metastases","volume":"47","author":"Song","year":"2006","journal-title":"J Nucl Med."},{"key":"2023061212152760000_50.3.233.18","first-page":"1977","article-title":"Lung toxicity in radioiodine therapy of thyroid carcinoma: development of a dose-rate method and dosimetric implications of the 80-mCi rule","volume":"47","author":"Sgouros","year":"2006","journal-title":"J Nucl Med."},{"key":"2023061212152760000_50.3.233.19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.semnuclmed.2016.10.002","article-title":"Radioiodine therapy","volume":"47","author":"Luster","year":"2017","journal-title":"Sem Nucl Med."},{"key":"2023061212152760000_50.3.233.20","doi-asserted-by":"crossref","first-page":"5279","DOI":"10.1118\/1.4961742","article-title":"Whole-remnant and maximum-voxel SPECT\/CT dosimetry in 131I-NaI treatments of differentiated thyroid cancer","volume":"43","author":"M\u00ednguez","year":"2016","journal-title":"Med Phys."},{"key":"2023061212152760000_50.3.233.21","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ejmp.2019.08.017","article-title":"Analysis of activity uptake, effective half-life and time-integrated activity for low- and high-risk papillary thyroid cancer patients treated with 1.11\u2009GBq and 3.7\u2009GBq of 131I-NaI respectively","volume":"65","author":"M\u00ednguez","year":"2019","journal-title":"Phys Med."},{"key":"2023061212152760000_50.3.233.22","first-page":"1132","article-title":"Radioiodine-131 therapy for well-differentiated thyroid cancer: a quantitative radiation dosimetric approach: outcome and validation in 85 patients","volume":"33","author":"Maxon","year":"1992","journal-title":"J Nucl Med."},{"key":"2023061212152760000_50.3.233.23","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.105148"},{"key":"2023061212152760000_50.3.233.24","first-page":"17-0111","article-title":"Dosing of radioactive iodine in end-stage renal disease patient with thyroid cancer","volume":"2017","author":"Bhat","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep."},{"key":"2023061212152760000_50.3.233.25","first-page":"619","article-title":"Impact of 131I diagnostic activities on the biokinetics of thyroid remnants","volume":"45","author":"Lassmann","year":"2004","journal-title":"J Nucl Med."},{"key":"2023061212152760000_50.3.233.26","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnm.0000169380.92270.73"},{"key":"2023061212152760000_50.3.233.27","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1590\/0100-3984.2015.0079","article-title":"Estimating 131I biokinetics and radiation doses to the red marrow and whole body in thyroid cancer patients: probe detection versus image quantification","volume":"49","author":"Willegaignon","year":"2016","journal-title":"Radiol Bras."},{"key":"2023061212152760000_50.3.233.28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/MNM.0000000000000465","article-title":"Prediction of iodine-131 biokinetics and radiation doses from therapy on the basis of tracer studies: an important question for therapy planning in nuclear medicine","volume":"37","author":"Willegaignon","year":"2016","journal-title":"Nucl Med Commun."},{"key":"2023061212152760000_50.3.233.29","unstructured":"de Barros PP. An\u00e1lise da radiometria realizada em pacientes submetidos \u00e0radioiodoterapia [dissertation]. Curso de P\u00f3s-Gradua\u00e7\u00e3o Strictu Sensu em Prote\u00e7\u00e3o Radiol?gica, Instituto Federal de Educa\u00e7\u00e3o, Ci\u00eancia e Tecnologia de Santa Catarina, Florian\u00f3polis, 2019."},{"key":"2023061212152760000_50.3.233.30","first-page":"35","article-title":"Evaluation of the effect of partial volume in the quantification of activity in PET\/CT images [in Portuguese]","volume":"6","author":"Krempser","year":"2012","journal-title":"Revista Brasileira de F\u00edsica M\u00e9dica."},{"key":"2023061212152760000_50.3.233.31","unstructured":"Aprova o protocolo cl\u00ednico e diretrizes terap\u00eautica do carcinoma diferenciado da tireoide. gov.br website. https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/pcdt\/arquivos\/2014\/carcinoma-diferenciado-da-tireoide-pcdt.pdf. Published January 3, 2014. Accessed August 2, 2022."}],"container-title":["Journal of Nuclear Medicine Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnmt.121.263502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T19:16:05Z","timestamp":1686597365000},"score":1,"resource":{"primary":{"URL":"http:\/\/tech.snmjournals.org\/lookup\/doi\/10.2967\/jnmt.121.263502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9,8]]},"published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.2967\/jnmt.121.263502"],"URL":"https:\/\/doi.org\/10.2967\/jnmt.121.263502","relation":{},"ISSN":["0091-4916","1535-5675"],"issn-type":[{"value":"0091-4916","type":"print"},{"value":"1535-5675","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,14]]}}}